BMAL1 Antibodies

Santa Cruz Biotechnology features a diverse variety of BMAL1 monoclonal antibodies for research in understanding the circadian rhythm and its regulatory mechanisms. BMAL1 monoclonal antibodies are suitable for various applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). BMAL1, or Brain and Muscle Arnt-Like 1, is a critical transcription factor that plays a pivotal role in the regulation of circadian rhythms by forming heterodimers with CLOCK. BMAL1 is essential for maintaining the body's internal clock, influencing various physiological processes such as sleep-wake cycles, metabolism, and hormone regulation. Understanding BMAL1 function is crucial for elucidating the mechanisms underlying circadian-related disorders and developing potential therapeutic strategies. Researchers worldwide rely on BMAL1 monoclonal antibodies to investigate molecular pathways involved in circadian rhythm regulation. Advanced research with BMAL1 monoclonal antibodies has revealed important insights into sleep disorders, metabolic diseases, and cancer biology. Current studies utilizing BMAL1 monoclonal antibodies continue to uncover new aspects of circadian biology and its impact on human health. Santa Cruz Biotechnology monoclonal antibodies support the scientific community in advancing our understanding of circadian rhythm regulation and its role in disease prevention and treatment.